Brief: Xbrane Biopharma Q2 EBITDA SEK -81.1 Million

Xbrane Biopharma AB

29/08/2023 07:00

Aug 29 (Reuters) - Xbrane Biopharma Q2 net income SEK -91 million.
* Q2 EPS SEK -3.22
* Q2 revenue SEK 51.1 million